Urologix Inc (ULGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,143 | -794 | -437 | -7,608 | -4,083 |
| Depreciation Amortization | 361 | 250 | 134 | 587 | 447 |
| Income taxes - deferred | 0 | 0 | 0 | -36 | 27 |
| Accounts receivable | 90 | -4 | -39 | 620 | 342 |
| Accounts payable and accrued liabilities | -184 | 42 | 37 | 264 | 387 |
| Other Working Capital | 148 | 88 | -34 | 1,163 | 1,037 |
| Other Operating Activity | 556 | 280 | 169 | 3,480 | 404 |
| Operating Cash Flow | $-172 | $-138 | $-170 | $-1,530 | $-1,439 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 1 | 4 | -1 | -32 | -28 |
| Purchase Sale Intangibles | -15 | -14 | -2 | -10 | -7 |
| Other Investing Activity | -55 | -54 | -2 | -10 | -7 |
| Investing Cash Flow | $-54 | $-50 | $-3 | $-42 | $-35 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 718 | 718 | 718 | 2,290 | 2,290 |
| End Cash Position | 492 | 530 | 545 | 718 | 816 |
| Net Cash Flow | $-226 | $-188 | $-173 | $-1,572 | $-1,474 |
| Free Cash Flow | |||||
| Operating Cash Flow | -172 | -138 | -170 | -1,530 | -1,439 |
| Capital Expenditure | -8 | -1 | -1 | -32 | -28 |
| Free Cash Flow | -180 | -139 | -171 | -1,562 | -1,467 |